Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBX-8025 in Overweight Hyperlipidemic Patients
NCT00701883Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of seladelpar in hyperlipidemia, obesity, sponsored by Gilead Sciences. Started Aug 2007; status: completed.
02
Drugs
seladelpar
03
Conditions
hyperlipidemiaobesity
Beyond the preview
Go deeper on NCT00701883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00701883.